首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1398343

腸胃藥的全球市場:～2029年

Global Gastrointestinal Drugs Market Insights, Forecast to 2029

出版日期: 2023年12月22日 | 出版商:

QYResearch | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

全球胃腸道藥物市場規模預計將從 2023 年的 409.226 億美元增長到 2029 年的 538.20 億美元，預測期內複合年增長率為 4.67%。

北美市場預計將從2023年的125.75億美元成長到2029年的162.38億美元，複合年增長率為4.35%。中國市場預計將從2023年的59.88億美元成長到2029年的86.7億美元，複合年增長率為6.36%。此外，歐洲市場預計到2029年將達到114.2億美元，複合年增長率為4.61%，較2023年的87.12億美元成長。

本報告提供全球腸胃藥的市場調查，彙整市場定義和概要，市場成長的各種影響因素分析，市場規模的轉變·預測，類型·各用途的明細，地區·各主要國家的詳細分析，競爭環境，主要企業簡介等資訊。

This report researches the key producers of Gastrointestinal Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Gastrointestinal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Gastrointestinal Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AstraZeneca, Sanofi, Bayer, Pfizer, GSK, Teva, Zeria, Perrigo, and Boehringer Ingelheim, etc.

By Company

Takeda
AstraZeneca
Bayer
Pfizer
Sun Pharma
Teva
Zeria
Perrigo
Eisai Co.
Abbvie
Jiangzhong
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Huadong Pharmaceutical
Bausch Health

Segment by Type

Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug

Segment by Application

Inflammatory Bowel Disease
IBS Disease
Peptic Ulcer
GERD
Other

Segment by Region

North America
- U.S.
- Canada

China

Asia (excluding China)
- Japan
- South Korea
- Southeast Asia
- India
- Australia

Europe
- Germany
- France
- UK
- Italy
- Russia

Middle East, Africa, Latin America
- Brazil
- Mexico
- Middle East
- Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Gastrointestinal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

1 STUDY COVERAGE

1.1 Gastrointestinal Drugs Product Introduction
1.2 Market by Type
- 1.2.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
- 1.2.2 Prescription Gastrointestinal Drug
- 1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
- 1.3.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
- 1.3.2 Inflammatory Bowel Disease
- 1.3.3 IBS Disease
- 1.3.4 Peptic Ulcer
- 1.3.5 GERD
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Gastrointestinal Drugs Revenue Estimates and Forecasts 2018-2029
2.2 Global Gastrointestinal Drugs Revenue by Region
- 2.2.1 Global Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029
- 2.2.2 Global Gastrointestinal Drugs Revenue by Region (2018-2023)
- 2.2.3 Global Gastrointestinal Drugs Revenue by Region (2024-2029)
- 2.2.4 Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Gastrointestinal Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Gastrointestinal Drugs Sales by Region
- 2.4.1 Global Gastrointestinal Drugs Sales by Region: 2018 VS 2022 VS 2029
- 2.4.2 Global Gastrointestinal Drugs Sales by Region (2018-2023)
- 2.4.3 Global Sales Gastrointestinal Drugs by Region (2024-2029)
- 2.4.4 Global Gastrointestinal Drugs Sales Market Share by Region (2018-2029)
2.5 North America
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURERS

3.1 Global Gastrointestinal Drugs Sales by Manufacturers
- 3.1.1 Global Gastrointestinal Drugs Sales by Manufacturers (2018-2023)
- 3.1.2 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2018-2023)
- 3.1.3 Global Top Largest Manufacturers of Gastrointestinal Drugs in 2022
3.2 Global Gastrointestinal Drugs Revenue by Manufacturers
- 3.2.1 Global Gastrointestinal Drugs Revenue by Manufacturers (2018-2023)
- 3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023)
- 3.2.3 Global Top Companies by Gastrointestinal Drugs Revenue in 2022
3.3 Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022
3.4 Global Gastrointestinal Drugs Sales Price by Manufacturers (2018-2023)
3.5 Analysis of Competitive Landscape
- 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.5.2 Global Gastrointestinal Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gastrointestinal Drugs, Founded Date
3.8 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

4.1 Global Gastrointestinal Drugs Sales by Type
- 4.1.1 Global Gastrointestinal Drugs Historical Sales by Type (2018-2023)
- 4.1.2 Global Gastrointestinal Drugs Forecasted Sales by Type (2024-2029)
- 4.1.3 Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
4.2 Global Gastrointestinal Drugs Revenue by Type
- 4.2.1 Global Gastrointestinal Drugs Historical Revenue by Type (2018-2023)
- 4.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Type (2024-2029)
- 4.2.3 Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Gastrointestinal Drugs Price by Type
- 4.3.1 Global Gastrointestinal Drugs Price by Type (2018-2023)
- 4.3.2 Global Gastrointestinal Drugs Price Forecast by Type (2024-2029)

5 MARKET SIZE BY APPLICATION

5.1 Global Gastrointestinal Drugs Sales by Application
- 5.1.1 Global Gastrointestinal Drugs Historical Sales by Application (2018-2023)
- 5.1.2 Global Gastrointestinal Drugs Forecasted Sales by Application (2024-2029)
- 5.1.3 Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
5.2 Global Gastrointestinal Drugs Revenue by Application
- 5.2.1 Global Gastrointestinal Drugs Historical Revenue by Application (2018-2023)
- 5.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Application (2024-2029)
- 5.2.3 Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Gastrointestinal Drugs Price by Application
- 5.3.1 Global Gastrointestinal Drugs Price by Application (2018-2023)
- 5.3.2 Global Gastrointestinal Drugs Price Forecast by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Gastrointestinal Drugs Market Size by Type
- 6.1.1 North America Gastrointestinal Drugs Sales by Type (2018-2029)
- 6.1.2 North America Gastrointestinal Drugs Revenue by Type (2018-2029)
6.2 North America Gastrointestinal Drugs Market Size by Application
- 6.2.1 North America Gastrointestinal Drugs Sales by Application (2018-2029)
- 6.2.2 North America Gastrointestinal Drugs Revenue by Application (2018-2029)
6.3 North America Gastrointestinal Drugs Market Size by Country
- 6.3.1 North America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029
- 6.3.2 North America Gastrointestinal Drugs Revenue by Country (2018-2029)
- 6.3.3 North America Gastrointestinal Drugs Sales by Country (2018-2029)
- 6.3.4 US
- 6.3.5 Canada

7 EUROPE

7.1 Europe Gastrointestinal Drugs Market Size by Type
- 7.1.1 Europe Gastrointestinal Drugs Sales by Type (2018-2029)
- 7.1.2 Europe Gastrointestinal Drugs Revenue by Type (2018-2029)
7.2 Europe Gastrointestinal Drugs Market Size by Application
- 7.2.1 Europe Gastrointestinal Drugs Sales by Application (2018-2029)
- 7.2.2 Europe Gastrointestinal Drugs Revenue by Application (2018-2029)
7.3 Europe Gastrointestinal Drugs Market Size by Country
- 7.3.1 Europe Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029
- 7.3.2 Europe Gastrointestinal Drugs Revenue by Country (2018-2029)
- 7.3.3 Europe Gastrointestinal Drugs Sales by Country (2018-2029)
- 7.3.4 Germany
- 7.3.5 France
- 7.3.6 UK
- 7.3.7 Italy
- 7.3.8 Russia

8 CHINA

8.1 China Gastrointestinal Drugs Market Size by Type
- 8.1.1 China Gastrointestinal Drugs Sales by Type (2018-2029)
- 8.1.2 China Gastrointestinal Drugs Revenue by Type (2018-2029)
8.2 China Gastrointestinal Drugs Market Size by Application
- 8.2.1 China Gastrointestinal Drugs Sales by Application (2018-2029)
- 8.2.2 China Gastrointestinal Drugs Revenue by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Gastrointestinal Drugs Market Size by Type
- 9.1.1 Asia Gastrointestinal Drugs Sales by Type (2018-2029)
- 9.1.2 Asia Gastrointestinal Drugs Revenue by Type (2018-2029)
9.2 Asia Gastrointestinal Drugs Market Size by Application
- 9.2.1 Asia Gastrointestinal Drugs Sales by Application (2018-2029)
- 9.2.2 Asia Gastrointestinal Drugs Revenue by Application (2018-2029)
9.3 Asia Gastrointestinal Drugs Market Size by Region
- 9.3.1 Asia Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029
- 9.3.2 Asia Gastrointestinal Drugs Revenue by Region (2018-2029)
- 9.3.3 Asia Gastrointestinal Drugs Sales by Region (2018-2029)
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 Southeast Asia
- 9.3.7 India
- 9.3.8 Australia

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

10.1 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Type
- 10.1.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2018-2029)
- 10.1.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Application
- 10.2.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2018-2029)
- 10.2.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Country
- 10.3.1 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029
- 10.3.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2018-2029)
- 10.3.3 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2018-2029)
- 10.3.4 Brazil
- 10.3.5 Mexico
- 10.3.6 Middle East
- 10.3.7 Africa

11 CORPORATE PROFILE

11.1 Takeda
- 11.1.1 Takeda Company Information
- 11.1.2 Takeda Overview
- 11.1.3 Takeda Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.1.4 Takeda Gastrointestinal Drugs Product Descriptions
- 11.1.5 Takeda Recent Developments
11.2 AstraZeneca
- 11.2.1 AstraZeneca Company Information
- 11.2.2 AstraZeneca Overview
- 11.2.3 AstraZeneca Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.2.4 AstraZeneca Gastrointestinal Drugs Product Descriptions
- 11.2.5 AstraZeneca Recent Developments
11.3 Bayer
- 11.3.1 Bayer Company Information
- 11.3.2 Bayer Overview
- 11.3.3 Bayer Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.3.4 Bayer Gastrointestinal Drugs Product Descriptions
- 11.3.5 Bayer Recent Developments
11.4 Pfizer
- 11.4.1 Pfizer Company Information
- 11.4.2 Pfizer Overview
- 11.4.3 Pfizer Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.4.4 Pfizer Gastrointestinal Drugs Product Descriptions
- 11.4.5 Pfizer Recent Developments
11.5 Sun Pharma
- 11.5.1 Sun Pharma Company Information
- 11.5.2 Sun Pharma Overview
- 11.5.3 Sun Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.5.4 Sun Pharma Gastrointestinal Drugs Product Descriptions
11.6 Teva
- 11.6.1 Teva Company Information
- 11.6.2 Teva Overview
- 11.6.3 Teva Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.6.4 Teva Gastrointestinal Drugs Product Descriptions
- 11.6.5 Teva Recent Developments
11.7 Zeria
- 11.7.1 Zeria Company Information
- 11.7.2 Zeria Overview
- 11.7.3 Zeria Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.7.4 Zeria Gastrointestinal Drugs Product Descriptions
- 11.7.5 Zeria Recent Developments
11.8 Perrigo
- 11.8.1 Perrigo Company Information
- 11.8.2 Perrigo Overview
- 11.8.3 Perrigo Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.8.4 Perrigo Gastrointestinal Drugs Product Descriptions
11.9 Eisai Co.
- 11.9.1 Eisai Co. Company Information
- 11.9.2 Eisai Co. Overview
- 11.9.3 Eisai Co. Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.9.4 Eisai Co. Gastrointestinal Drugs Product Descriptions
11.10 Abbvie
- 11.10.1 Abbvie Company Information
- 11.10.2 Abbvie Overview
- 11.10.3 Abbvie Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.10.4 Abbvie Gastrointestinal Drugs Product Descriptions
- 11.10.5 Abbvie Recent Developments
11.11 Jiangzhong
- 11.11.1 Jiangzhong Company Information
- 11.11.2 Jiangzhong Overview
- 11.11.3 Jiangzhong Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.11.4 Jiangzhong Gastrointestinal Drugs Product Descriptions
11.12 AOSAIKANG Pharma
- 11.12.1 AOSAIKANG Pharma Company Information
- 11.12.2 AOSAIKANG Pharma Overview
- 11.12.3 AOSAIKANG Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.12.4 AOSAIKANG Pharma Gastrointestinal Drugs Product Descriptions
11.13 Luoxin Pharma
- 11.13.1 Luoxin Pharma Company Information
- 11.13.2 Luoxin Pharma Overview
- 11.13.3 Luoxin Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.13.4 Luoxin Pharma Gastrointestinal Drugs Product Descriptions
11.14 LIVZON
- 11.14.1 LIVZON Company Information
- 11.14.2 LIVZON Overview
- 11.14.3 LIVZON Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.14.4 LIVZON Gastrointestinal Drugs Product Descriptions
11.15 Huadong Pharmaceutical
- 11.15.1 Huadong Pharmaceutical Company Information
- 11.15.2 Huadong Pharmaceutical Overview
- 11.15.3 Huadong Pharmaceutical Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.15.4 Huadong Pharmaceutical Gastrointestinal Drugs Product Descriptions
11.16 Bausch Health
- 11.16.1 Bausch Health Company Information
- 11.16.2 Bausch Health Overview
- 11.16.3 Bausch Health Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.16.4 Bausch Health Gastrointestinal Drugs Product Descriptions
- 11.16.5 Bausch Health Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

12.1 Gastrointestinal Drugs Industry Chain Analysis
12.2 Gastrointestinal Drugs Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
12.3 Gastrointestinal Drugs Production Mode & Process
12.4 Gastrointestinal Drugs Sales and Marketing
- 12.4.1 Gastrointestinal Drugs Sales Channels
- 12.4.2 Gastrointestinal Drugs Distributors
12.5 Gastrointestinal Drugs Customers

13 GASTROINTESTINAL DRUGS MARKET DYNAMICS

13.1.1 Gastrointestinal Drugs Industry Trends
13.1.2 Gastrointestinal Drugs Market Drivers
13.1.3 Gastrointestinal Drugs Market Challenges
13.1.4 Gastrointestinal Drugs Market Restraints

14 KEY FINDINGS IN THE GLOBAL GASTROINTESTINAL DRUGS STUDY

15 APPENDIX

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

簡介目錄圖表

List of Tables

Table 1. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 3. Global Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 5. Global Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 6. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2023)
Table 7. Global Gastrointestinal Drugs Revenue Market Share by Region (2024-2029)
Table 8. Global Gastrointestinal Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (M Units)
Table 9. Global Gastrointestinal Drugs Sales by Region (2018-2023) & (M Units)
Table 10. Global Gastrointestinal Drugs Sales by Region (2024-2029) & (M Units)
Table 11. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2023)
Table 12. Global Gastrointestinal Drugs Sales Market Share by Region (2024-2029)
Table 13. Global Gastrointestinal Drugs Sales by Manufacturers (2018-2023) & (M Units)
Table 14. Global Gastrointestinal Drugs Sales Share by Manufacturers (2018-2023)
Table 15. Global Gastrointestinal Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 16. Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023)
Table 17. Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022
Table 18. Gastrointestinal Drugs Price by Manufacturers (2018-2023) & (USD/Unit)
Table 19. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2022)
Table 21. Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters
Table 22. Global Key Manufacturers of Gastrointestinal Drugs, Founded Date
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
Table 25. Global Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
Table 26. Global Gastrointestinal Drugs Sales Share by Type (2018-2023)
Table 27. Global Gastrointestinal Drugs Sales Share by Type (2024-2029)
Table 28. Global Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 29. Global Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 30. Global Gastrointestinal Drugs Revenue Share by Type (2018-2023)
Table 31. Global Gastrointestinal Drugs Revenue Share by Type (2024-2029)
Table 32. Gastrointestinal Drugs Price by Type (2018-2023) & (USD/Unit)
Table 33. Global Gastrointestinal Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 34. Global Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
Table 35. Global Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
Table 36. Global Gastrointestinal Drugs Sales Share by Application (2018-2023)
Table 37. Global Gastrointestinal Drugs Sales Share by Application (2024-2029)
Table 38. Global Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 39. Global Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 40. Global Gastrointestinal Drugs Revenue Share by Application (2018-2023)
Table 41. Global Gastrointestinal Drugs Revenue Share by Application (2024-2029)
Table 42. Gastrointestinal Drugs Price by Application (2018-2023) & (USD/Unit)
Table 43. Global Gastrointestinal Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 44. North America Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
Table 45. North America Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
Table 46. North America Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 47. North America Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 48. North America Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
Table 49. North America Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
Table 50. North America Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 51. North America Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 52. North America Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 53. North America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 54. North America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 55. North America Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units)
Table 56. North America Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units)
Table 57. Europe Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
Table 58. Europe Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
Table 59. Europe Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 60. Europe Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 61. Europe Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
Table 62. Europe Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
Table 63. Europe Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 64. Europe Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 65. Europe Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Europe Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 67. Europe Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 68. Europe Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units)
Table 69. Europe Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units)
Table 70. China Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
Table 71. China Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
Table 72. China Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 73. China Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 74. China Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
Table 75. China Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
Table 76. China Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 77. China Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 78. Asia Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
Table 79. Asia Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
Table 80. Asia Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 81. Asia Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 82. Asia Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
Table 83. Asia Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
Table 84. Asia Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 85. Asia Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 86. Asia Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 87. Asia Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 88. Asia Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 89. Asia Gastrointestinal Drugs Sales by Region (2018-2023) & (M Units)
Table 90. Asia Gastrointestinal Drugs Sales by Region (2024-2029) & (M Units)
Table 91. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units)
Table 92. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units)
Table 93. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 94. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 95. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units)
Table 96. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units)
Table 97. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 100. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units)
Table 103. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units)
Table 104. Takeda Company Information
Table 105. Takeda Description and Major Businesses
Table 106. Takeda Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Takeda Gastrointestinal Drugs Product Descriptions
Table 108. Takeda Recent Developments
Table 109. AstraZeneca Company Information
Table 110. AstraZeneca Description and Major Businesses
Table 111. AstraZeneca Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. AstraZeneca Gastrointestinal Drugs Product Descriptions
Table 113. AstraZeneca Recent Developments
Table 114. Bayer Company Information
Table 115. Bayer Description and Major Businesses
Table 116. Bayer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Bayer Gastrointestinal Drugs Product Descriptions
Table 118. Bayer Recent Developments
Table 119. Pfizer Company Information
Table 120. Pfizer Description and Major Businesses
Table 121. Pfizer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Pfizer Gastrointestinal Drugs Product Descriptions
Table 123. Pfizer Recent Developments
Table 124. Sun Pharma Company Information
Table 125. Sun Pharma Description and Major Businesses
Table 126. Sun Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Sun Pharma Gastrointestinal Drugs Product Descriptions
Table 128. Teva Company Information
Table 129. Teva Description and Major Businesses
Table 130. Teva Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Teva Gastrointestinal Drugs Product Descriptions
Table 132. Teva Recent Developments
Table 133. Zeria Company Information
Table 134. Zeria Description and Major Businesses
Table 135. Zeria Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Zeria Gastrointestinal Drugs Product Descriptions
Table 137. Zeria Recent Developments
Table 138. Perrigo Company Information
Table 139. Perrigo Description and Major Businesses
Table 140. Perrigo Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Perrigo Gastrointestinal Drugs Product Descriptions
Table 142. Eisai Co. Company Information
Table 143. Eisai Co. Description and Major Businesses
Table 144. Eisai Co. Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Eisai Co. Gastrointestinal Drugs Product Descriptions
Table 146. Abbvie Company Information
Table 147. Abbvie Description and Major Businesses
Table 148. Abbvie Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 149. Abbvie Gastrointestinal Drugs Product Descriptions
Table 150. Abbvie Recent Developments
Table 151. Jiangzhong Company Information
Table 152. Jiangzhong Description and Major Businesses
Table 153. Jiangzhong Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 154. Jiangzhong Gastrointestinal Drugs Product Descriptions
Table 155. AOSAIKANG Pharma Company Information
Table 156. AOSAIKANG Pharma Description and Major Businesses
Table 157. AOSAIKANG Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. AOSAIKANG Pharma Gastrointestinal Drugs Product Descriptions
Table 159. Luoxin Pharma Company Information
Table 160. Luoxin Pharma Description and Major Businesses
Table 161. Luoxin Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 162. Luoxin Pharma Gastrointestinal Drugs Product Descriptions
Table 163. LIVZON Company Information
Table 164. LIVZON Description and Major Businesses
Table 165. LIVZON Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 166. LIVZON Gastrointestinal Drugs Product Descriptions
Table 167. Huadong Pharmaceutical Company Information
Table 168. Huadong Pharmaceutical Description and Major Businesses
Table 169. Huadong Pharmaceutical Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 170. Huadong Pharmaceutical Gastrointestinal Drugs Product Descriptions
Table 171. Bausch Health Company Information
Table 172. Bausch Health Description and Major Businesses
Table 173. Bausch Health Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 174. Bausch Health Gastrointestinal Drugs Product Descriptions
Table 175. Bausch Health Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Gastrointestinal Drugs Distributors List
Table 179. Gastrointestinal Drugs Customers List
Table 180. Gastrointestinal Drugs Market Trends
Table 181. Gastrointestinal Drugs Market Drivers
Table 182. Gastrointestinal Drugs Market Challenges
Table 183. Gastrointestinal Drugs Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
Table 187. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Gastrointestinal Drugs Product Picture
Figure 2. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018-2029 (US$ Million)
Figure 3. Global Gastrointestinal Drugs Market Share by Type: 2022
Figure 4. Global Gastrointestinal Drugs Market Share by Type: 2029
Figure 5. Prescription Gastrointestinal Drug Product Picture
Figure 6. OTC Gastrointestinal Drug Product Picture
Figure 7. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Gastrointestinal Drugs Market Share by Application: 2022
Figure 9. Global Gastrointestinal Drugs Market Share by Application: 2029
Figure 10. Inflammatory Bowel Disease
Figure 11. IBS Disease
Figure 12. Peptic Ulcer
Figure 13. GERD
Figure 14. Gastrointestinal Drugs Report Years Considered
Figure 15. Global Gastrointestinal Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Gastrointestinal Drugs Revenue 2018-2029 (US$ Million)
Figure 17. Global Gastrointestinal Drugs Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 18. Global Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2022
Figure 19. Global Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2029
Figure 20. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2029)
Figure 21. Global Gastrointestinal Drugs Sales 2018-2029 (M Units)
Figure 22. Global Gastrointestinal Drugs Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (M Units)
Figure 23. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2029)
Figure 24. North America Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
Figure 25. North America Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Europe Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
Figure 27. Europe Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. China Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
Figure 29. China Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Asia (excluding China) Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
Figure 31. Asia (excluding China) Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units)
Figure 33. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 34. The Gastrointestinal Drugs Market Share of Top Largest Manufacturers Around the World in 2022
Figure 35. The Top Largest Manufacturers of Gastrointestinal Drugs in the World: Market Share by Gastrointestinal Drugs Revenue in 2022
Figure 36. Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
Figure 37. Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
Figure 38. Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
Figure 39. Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
Figure 40. North America Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
Figure 41. North America Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
Figure 42. North America Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
Figure 43. North America Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
Figure 44. North America Gastrointestinal Drugs Revenue Share by Country (2018-2029)
Figure 45. North America Gastrointestinal Drugs Sales Share by Country (2018-2029)
Figure 46. US Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
Figure 49. Europe Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
Figure 50. Europe Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
Figure 51. Europe Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
Figure 52. Europe Gastrointestinal Drugs Revenue Share by Country (2018-2029)
Figure 53. Europe Gastrointestinal Drugs Sales Share by Country (2018-2029)
Figure 54. Germany Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. France Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. UK Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 59. China Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
Figure 60. China Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
Figure 61. China Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
Figure 62. China Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
Figure 63. Asia Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
Figure 64. Asia Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
Figure 65. Asia Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
Figure 66. Asia Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
Figure 67. Asia Gastrointestinal Drugs Revenue Share by Region (2018-2029)
Figure 68. Asia Gastrointestinal Drugs Sales Share by Region (2018-2029)
Figure 69. Japan Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. India Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 73. Australia Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Gastrointestinal Drugs Sales Share by Country (2018-2029)
Figure 78. Brazil Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Middle East Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Africa Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Gastrointestinal Drugs Value Chain
Figure 83. Gastrointestinal Drugs Production Process (Capsule)
Figure 84. Gastrointestinal Drugs Production Process (Injection)
Figure 85. Gastrointestinal Drugs Production Process (Tablet)
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed